Results
|
|
321.
|
Maintenance of virologic efficacy and decrease in levels of β2-microglobulin, soluble CD40L and soluble CD14 after switching previously treated HIV-infected patients to an NRTI-sparing dual therapy. [electronic resource] by
- Romero-Sánchez, M Concepción
- Alvarez-Ríos, Ana I
- Bernal-Morell, Enrique
- Genebat, Miguel
- Vera, Francisco
- Benhnia, Mohammed Rafii-El-Idrissi
- Bravo-Urbieta, Joaquín
- Galera-Peñaranda, Carlos
- de Pablo-Bernal, Rebeca S
- Abad-Carrillo, María Antonia
- Leal, Manuel
- Ruiz-Mateos, Ezequiel
Producer: 20150721
In:
Antiviral research vol. 111
Availability: No items available.
|
|
|
322.
|
A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity. [electronic resource] by
- Garcia-Perez, Javier
- Staropoli, Isabelle
- Azoulay, Stéphane
- Heinrich, Jean-Thomas
- Cascajero, Almudena
- Colin, Philippe
- Lortat-Jacob, Hugues
- Arenzana-Seisdedos, Fernando
- Alcami, Jose
- Kellenberger, Esther
- Lagane, Bernard
Producer: 20160324
In:
Retrovirology vol. 12
Availability: No items available.
|
|
|
323.
|
Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients. [electronic resource] by
- Bocket, L
- Peytavin, G
- Alidjinou, E K
- Ajana, F
- Choisy, P
- Lê, M
- Charpentier, C
- Descamps, D
- Yazdanpanah, Yazdan
- Katlama, C
- Simon, A
- Calvez, V
- Marcelin, A-G
- Soulie, C
Producer: 20170818
In:
The Journal of antimicrobial chemotherapy vol. 71
Availability: No items available.
|
|
|
324.
|
|
|
|
325.
|
|
|
|
326.
|
Maraviroc treatment in non-R5-HIV-1-infected patients results in the selection of extreme CXCR4-using variants with limited effect on the total viral setpoint. [electronic resource] by
- McGovern, Rachel A
- Symons, Jori
- Poon, Art F Y
- Harrigan, P Richard
- van Lelyveld, Steven F L
- Hoepelman, Andy I M
- van Ham, Petra M
- Dong, Winnie
- Wensing, Annemarie M J
- Nijhuis, Monique
Producer: 20140331
In:
The Journal of antimicrobial chemotherapy vol. 68
Availability: No items available.
|
|
|
327.
|
|
|
|
328.
|
|
|
|
329.
|
Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maraviroc. [electronic resource] by
- Forbes, Claire J
- Lowry, Deborah
- Geer, Leslie
- Veazey, Ronald S
- Shattock, Robin J
- Klasse, Per Johan
- Mitchnick, Mark
- Goldman, Laurie
- Doyle, Lara A
- Muldoon, Brendan C O
- Woolfson, A David
- Moore, John P
- Malcolm, R Karl
Producer: 20120307
In:
Journal of controlled release : official journal of the Controlled Release Society vol. 156
Availability: No items available.
|
|
|
330.
|
The CCL5/CCR5 axis contributes to the perineural invasion of human salivary adenoid cystic carcinoma. [electronic resource] by
- Shen, Zhiyuan
- Li, Tianyi
- Chen, Da
- Jia, Sen
- Yang, Xiangming
- Liang, Liang
- Chai, Juan
- Cheng, Xiaobing
- Yang, Xinjie
- Sun, Moyi
Producer: 20140903
In:
Oncology reports vol. 31
Availability: No items available.
|
|
|
331.
|
Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study. [electronic resource] by
- Katlama, Christine
- Assoumou, Lambert
- Valantin, Marc-Antoine
- Soulié, Cathia
- Duvivier, Claudine
- Chablais, Laetitia
- Kolta, Sami
- Pialoux, Gilles
- Mercié, Patrick
- Simon, Anne
- Costagliola, Dominique
- Peytavin, Gilles
- Marcelin, Anne-Genevieve
Producer: 20150114
In:
The Journal of antimicrobial chemotherapy vol. 69
Availability: No items available.
|
|
|
332.
|
|
|
|
333.
|
Translational Approach to Predicting the Efficacy of Maraviroc-Based Regimens as HIV Preexposure Prophylaxis. [electronic resource] by
- Srinivas, Nithya
- Cottrell, Mackenzie
- Maffuid, Kaitlyn
- Prince, Heather A
- Nelson, Julie A E
- White, Nicole
- Sykes, Craig
- Dellon, Evan S
- Madanick, Ryan D
- Shaheen, Nicholas J
- Gonzalez, Daniel
- Kashuba, Angela D M
Producer: 20210104
In:
Antimicrobial agents and chemotherapy vol. 64
Availability: No items available.
|
|
|
334.
|
|
|
|
335.
|
HIV-1 predisposed to acquiring resistance to maraviroc (MVC) and other CCR5 antagonists in vitro has an inherent, low-level ability to utilize MVC-bound CCR5 for entry. [electronic resource] by
- Roche, Michael
- Jakobsen, Martin R
- Ellett, Anne
- Salimiseyedabad, Hamid
- Jubb, Becky
- Westby, Mike
- Lee, Benhur
- Lewin, Sharon R
- Churchill, Melissa J
- Gorry, Paul R
Producer: 20120130
In:
Retrovirology vol. 8
Availability: No items available.
|
|
|
336.
|
|
|
|
337.
|
Safety, efficacy and indications of prescription of maraviroc in clinical practice: Factors associated with clinical outcomes. [electronic resource] by
- Llibre, Josep M
- Rivero, Antonio
- Rojas, Jhon F
- Garcia Del Toro, Miguel
- Herrero, Cristina
- Arroyo, David
- Pineda, Juan A
- Pasquau, Juan
- Masiá, Mar
- Crespo, Manel
- Blanco, José R
- Moreno, Santiago
Producer: 20160322
In:
Antiviral research vol. 120
Availability: No items available.
|
|
|
338.
|
HIV-2 X4 tropism is associated with lower CD4+ cell count in treatment-experienced patients. [electronic resource] by
- Visseaux, Benoit
- Charpentier, Charlotte
- Rouard, Caroline
- Fagard, Catherine
- Glohi, David
- Tubiana, Roland
- Damond, Florence
- Brun-Vézinet, Françoise
- Matheron, Sophie
- Descamps, Diane
Producer: 20150601
In:
AIDS (London, England) vol. 28
Availability: No items available.
|
|
|
339.
|
|
|
|
340.
|
|